News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The 2/20/20 risk-stratification model for smoldering multiple myeloma
Photo taken from Multiple Myeloma Research Foundation/X
Jul 9, 2024, 10:34

The 2/20/20 risk-stratification model for smoldering multiple myeloma

Multiple Myeloma Research Foundation shared a post on X:

“The 2/20/20 risk-stratification model was developed to determine which patients with SMM (smoldering multiple myeloma) are at high risk for progression to myeloma. Patients with 2 or more risk factors are considered high risk. To learn more, download our Precursor Conditions booklet.”

Source: Multiple Myeloma Research Foundation/X

cancer Multiple Myeloma Research Foundation Myeloma OncoDaily Oncology Precursor Conditions booklet risk-stratification model SMM Smoldering multiple myeloma
Special Coverage
Voices
Aug 13, 2025, 12:25
Zainab Shinkafi-Bagudu: Over 70% of Cancer Cases in LMICs are Diagnosed at Advanced Stages
Opinion
Aug 13, 2025, 12:25
Christian Ramsoomair Awarded $220K NCI Fellowship to Advance Pediatric Brain Cancer Research
Career Updates
Aug 13, 2025, 12:24
Vinay Prasad Rejoins FDA Days After Exit
New Paper Alert
Aug 13, 2025, 12:24
New Paper Alert: Safety and Outcomes of T-DXd Retreatment After Grade 1 ILD Recovery
Voices
Aug 13, 2025, 12:19
Case Comprehensive Cancer Center Receives $25.5M Grant Renewal for Cancer Research and Innovation
Voices
Aug 13, 2025, 12:02
Svetlana Nikic: Promise for Faster, More Comprehensive Gene Fusion Detection in Cancer
Voices
Aug 13, 2025, 11:53
Yan Leyfman Highlights mRNA Multi-Target CAR T Triumphs in Glioblastoma Models
Voices
Aug 13, 2025, 11:52
Elena Laakmann: The Survey Results on Brain Imaging in Patients with Metastatic Breast Cancer
Science
Aug 13, 2025, 11:36
Xiuning Le: Celebrating the FDA Approval of Zongertinib as the First TKI for HER2-Mutant NSCLC
Voices
Aug 13, 2025, 11:24
Join us at the NSW Cancer Summit 2025 - Cancer Institute NSW
Voices
Aug 13, 2025, 10:50
Digestive Cancers Europe Empowers Patients with Key Questions for Appendix Cancer and PMP Care
Voices
Aug 13, 2025, 10:46
John Paul Shen on Targeting One of the Body’s Most Elusive Cancers - Conquer Cancer, the ASCO Foundation